Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D03NTQ
|
||||
| Former ID |
DNC013999
|
||||
| Drug Name |
7-Phenyl-1-(pyridazin-3-yl)-heptan-1-one
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [529594] | ||
| Formula |
C17H20N2O
|
||||
| Canonical SMILES |
C1=CC=C(C=C1)CCCCCCC(=O)C2=NN=CC=C2
|
||||
| InChI |
1S/C17H20N2O/c20-17(16-12-8-14-18-19-16)13-7-2-1-4-9-15-10-5-3-6-11-15/h3,5-6,8,10-12,14H,1-2,4,7,9,13H2
|
||||
| InChIKey |
DXGZKZUTNHLJNE-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Fatty-acid amide hydrolase | Target Info | Inhibitor | [529594] | |
| BioCyc Pathway | Anandamide degradation | ||||
| KEGG Pathway | Retrograde endocannabinoid signaling | ||||
| PANTHER Pathway | Anandamide degradation | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.